(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-23 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 882820
Date | Daily Closing Price | Open | High | Low | Volume |
23 Wed Oct 2024 | 46.00 | 47.95 | 47.96 | 45.44 | 2.07 times |
22 Tue Oct 2024 | 48.04 | 48.26 | 48.42 | 47.82 | 0.945 times |
21 Mon Oct 2024 | 48.51 | 48.59 | 48.94 | 48.20 | 0.893 times |
18 Fri Oct 2024 | 48.92 | 48.55 | 49.24 | 48.40 | 0.886 times |
17 Thu Oct 2024 | 48.29 | 48.91 | 49.28 | 48.25 | 1.304 times |
16 Wed Oct 2024 | 49.00 | 48.32 | 49.25 | 47.90 | 1.138 times |
15 Tue Oct 2024 | 48.05 | 47.86 | 48.54 | 47.20 | 0.983 times |
14 Mon Oct 2024 | 47.83 | 46.74 | 47.88 | 46.10 | 1.185 times |
11 Fri Oct 2024 | 46.85 | 45.28 | 47.50 | 45.03 | 1.256 times |
10 Thu Oct 2024 | 45.39 | 45.01 | 45.70 | 44.50 | 0.652 times |
Stock of Crispr Therapeutics (CRSP) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 45.4 as stoploss in an intra day buy trade for a target of 46.77. However, stock will show a bearish move below 45.4.
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 43.42 |
Downside Target | 44.44 |
Upside Target | 47.50 |
Upside Target | 49.28 |
Upside Target | 51.99 |
Upside Target | 52.31 |
Upside Target | 53.33 |
Upside Target | 57.68 |
Upside Target | 63.68 |
Upside Target | 67.88 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 44.65 |
Downside Intraday Target | 43.29 |
Upside Intraday Target | 48.15 |
Upside Intraday Target | 50.29 |
Upside Intraday Target | 46.79 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
23 Wed Oct 2024 | 46.00 | 48.59 | 48.94 | 45.44 | 0.711 times |
18 Fri Oct 2024 | 48.92 | 46.74 | 49.28 | 46.10 | 1.151 times |
11 Fri Oct 2024 | 46.85 | 45.43 | 47.50 | 44.44 | 0.773 times |
04 Fri Oct 2024 | 45.37 | 46.94 | 47.69 | 44.61 | 1.222 times |
27 Fri Sep 2024 | 47.32 | 48.54 | 48.56 | 45.83 | 0.604 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
23 Wed Oct 2024 | 46.00 | 47.00 | 49.28 | 44.44 | 0.809 times |
30 Mon Sep 2024 | 46.98 | 47.37 | 51.99 | 43.42 | 0.769 times |
30 Fri Aug 2024 | 47.72 | 57.39 | 57.68 | 44.80 | 0.967 times |
31 Wed Jul 2024 | 57.29 | 54.02 | 63.68 | 52.31 | 0.995 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.59 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.59 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.